Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

14.40
-0.3000-2.04%
Post-market: 14.450.0500+0.35%19:58 EDT
Volume:3.62M
Turnover:52.30M
Market Cap:1.64B
PE:-3.98
High:15.21
Open:15.20
Low:14.02
Close:14.70
Loading ...
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]